Emily F. Mason, Ph.D. - Publications

Affiliations: 
2011 Molecular Cancer Biology Duke University, Durham, NC 
Area:
Molecular Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Mason EF, Brown RD, Szeto DP, Gibson CJ, Jia Y, Garcia EP, Jacobson CA, Dal Cin P, Kuo FC, Pinkus GS, Lindeman NI, Sholl LM, Aster JC, Morgan EA. Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant. Leukemia & Lymphoma. 1-4. PMID 27241017 DOI: 10.1080/10428194.2016.1185786  0.48
2013 Kluk MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA, Dorfman D, Pinkus G, Weigert O, Hornick JL, Chirieac LR, Hirsch M, Oh DJ, South AP, Leigh IM, et al. Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry. Plos One. 8: e67306. PMID 23825651 DOI: 10.1371/journal.pone.0067306  0.48
2013 Mason EF, Sadow PM, Wagner AJ, Remillard SP, Flood TA, Belanger EC, Hornick JL, Barletta JA. Identification of succinate dehydrogenase-deficient bladder paragangliomas. The American Journal of Surgical Pathology. 37: 1612-8. PMID 23797725 DOI: 10.1097/PAS.0b013e318293d83c  0.48
2013 Mason EF, Hornick JL. Succinate dehydrogenase deficiency is associated with decreased 5-hydroxymethylcytosine production in gastrointestinal stromal tumors: implications for mechanisms of tumorigenesis. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 1492-7. PMID 23743927 DOI: 10.1038/modpathol.2013.86  0.48
2011 Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, Sullivan SA, Nichols AG, Rathmell JC. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. Journal of Immunology (Baltimore, Md. : 1950). 186: 3299-303. PMID 21317389 DOI: 10.4049/jimmunol.1003613  0.48
2011 Coloff JL, Mason EF, Altman BJ, Gerriets VA, Liu T, Nichols AN, Zhao Y, Wofford JA, Jacobs SR, Ilkayeva O, Garrison SP, Zambetti GP, Rathmell JC. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells. The Journal of Biological Chemistry. 286: 5921-33. PMID 21159778 DOI: 10.1074/jbc.M110.179101  0.48
2011 Altman BJ, Jacobs SR, Mason EF, Michalek RD, MacIntyre AN, Coloff JL, Ilkayeva O, Jia W, He YW, Rathmell JC. Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. Oncogene. 30: 1855-67. PMID 21151168 DOI: 10.1038/onc.2010.561  0.48
2011 Mason EF, Rathmell JC. Cell metabolism: an essential link between cell growth and apoptosis. Biochimica Et Biophysica Acta. 1813: 645-54. PMID 20816705 DOI: 10.1016/j.bbamcr.2010.08.011  0.48
2010 Mason EF, Zhao Y, Goraksha-Hicks P, Coloff JL, Gannon H, Jones SN, Rathmell JC. Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl. Cancer Research. 70: 8066-76. PMID 20876800 DOI: 10.1158/0008-5472.CAN-10-0608  0.48
2008 Morrell CN, Murata K, Swaim AM, Mason E, Martin TV, Thompson LE, Ballard M, Fox-Talbot K, Wasowska B, Baldwin WM. In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circulation Research. 102: 777-85. PMID 18296616 DOI: 10.1161/CIRCRESAHA.107.170332  0.48
2008 Morrell CN, Sun H, Ikeda M, Beique JC, Swaim AM, Mason E, Martin TV, Thompson LE, Gozen O, Ampagoomian D, Sprengel R, Rothstein J, Faraday N, Huganir R, Lowenstein CJ. Glutamate mediates platelet activation through the AMPA receptor. The Journal of Experimental Medicine. 205: 575-84. PMID 18283118 DOI: 10.1084/jem.20071474  0.48
Show low-probability matches.